Stay updated with breaking news from Herbert Fritsche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has sold four patent applications and all associated
Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center
27.01.2022 - Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas to the Board of Directors• ... Seite 1
Investegate announcements from Apollon Formularies, Completion of High-Volume Processing Laboratory
Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers) USA - English Share this article Aion Therapeutic Inc. (CSE: AION) (" Aion Therapeutic" or the " Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical cannabis and medicinal mushroom preparations for the treatment of interstitial cystitis and other bladder diseases, and metho...